Akouos Inc (AKUS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
13.29 +0.14 (+1.06%) 11/30/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 13.29 unch (unch) -
for Wed, Nov 30th, 2022
Results
download Want to compare other data? Select Fields| Symbol | AKUS | CTKB | GHRS | ||
| Company | Akouos Inc | Cytek Biosciences Inc | Gh Research Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.20 | 3.84 | 9.23 | ||
| High | 13.33 | 3.85 | 9.29 | ||
| Low | 13.16 | 3.81 | 9.21 | ||
| Last | 13.29 | 3.79 | 9.14 | ||
| Change | +0.14 | -0.07 | -0.26 | ||
| % Change | +1.06% | -1.81% | -2.77% | ||
| Volume | 1,790,400 | 4,300 | 8,667 | ||
| 20-Day Average Volume | 593,120 | 739,236 | 197,537 | ||
| Previous Close | 13.15 | 3.86 | 9.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.27 | 3.73 | 9.39 | ||
| 20-Day Raw Stochastic | 48.33% | 67.47% | 40.58% | ||
| 20-Day Relative Strength | 73.87% | 43.62% | 42.92% | ||
| Weighted Alpha | -10.80 | -50.39 | -31.18 | ||
| Today's Opinion | 100% Buy | 88% Sell | 40% Sell | ||
| Previous Opinion | 88% Buy | 88% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.99% since 11/22/22 | +1.06% since 04/22/25 | -1.91% since 04/22/25 | ||
| Low | 13.10 on 11/28/22 | 3.72 on 04/25/25 | 9.20 on 04/25/25 | ||
| High | 13.33 on 11/30/22 | 4.05 on 04/23/25 | 10.00 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +0.91% since 10/28/22 | -4.25% since 03/28/25 | -16.55% since 03/28/25 | ||
| Low | 13.00 on 11/14/22 | 3.27 on 04/09/25 | 7.98 on 04/09/25 | ||
| High | 13.60 on 11/10/22 | 4.10 on 04/02/25 | 11.28 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +289.74% since 08/30/22 | -32.69% since 01/29/25 | -2.12% since 01/29/25 | ||
| Low | 3.07 on 09/08/22 | 3.27 on 04/09/25 | 7.98 on 04/09/25 | ||
| High | 13.60 on 11/10/22 | 5.84 on 01/30/25 | 20.50 on 02/03/25 | ||
| 6-Month | |||||
| %Chg | +385.04% since 05/27/22 | -20.37% since 10/29/24 | +13.95% since 10/29/24 | ||
| Low | 2.51 on 08/09/22 | 3.27 on 04/09/25 | 6.72 on 12/20/24 | ||
| High | 13.60 on 11/10/22 | 7.63 on 11/07/24 | 20.50 on 02/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 490,879 | 494,454 | 489,063 | ||
| Shares Outstanding, K | 36,936 | 128,097 | 52,028 | ||
| Annual Sales | 0 | 200,450,000 | 0 | ||
| Annual Net Income | -86,670,000 | -6,020,000 | -38,960,000 | ||
| Last Quarter Sales | 0 | 57,480,000 | 0 | ||
| Last Quarter Net Income | -19,840,000 | 9,640,000 | -8,800,000 | ||
| 60-Month Beta | -0.55 | 1.41 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 11/14/22 | 0.07 on 02/27/25 | -0.17 on 02/27/25 | ||
| Latest Earnings Date | 11/11/22 | 05/08/25 | 05/02/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||